Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Metformin and 2-Deoxyglucose Collaboratively Suppress Human CD4+ T Cell Inflammatory Functions and Activation-Induced Metabolic Reprogramming

ABSTRACT: Metformin and 2-Deoxyglucose Collaboratively Suppress Human CD4+ T Cell Inflammatory Functions and Activation-Induced Metabolic Reprogramming

PROVIDER: PRJNA605011 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR11031236.fastq.gz	Fastqsanger.gz
	SRR11031237.fastq.gz	Fastqsanger.gz
	SRR11031238.fastq.gz	Fastqsanger.gz
	SRR11031239.fastq.gz	Fastqsanger.gz
	SRR11031240.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 41

Similar Datasets

Untargeted transcriptomic profiling of activated primary human CD4+ T cells treated with metformin and 2-deoxyglucose

Project description:Purpose: To investigate the effects of metabolic inhibitors metformin and 2-deoxyglucose on the global transcriptome of primary human CD4+ T cells. Methods: mRNA profiles of primary human CD4+ T cells were generated by RNA-Seq for 3 donors in triplicate using Illumina TruSeq library prep. Data was processed using Elucidata's workflow as described below. Results: Our study presents the first transcriptomic analysis of how metformin + 2-deoxyglucose combination treatment affects activation-induced remodeling of metabolic gene expression in primary human CD4+ T cells.

2020-06-15 | GSE144353 | GEO

Untargeted transcriptomic profiling of activated primary human CD4+ T cells treated with metformin and 2-deoxyglucose

Project description:Untargeted transcriptomic profiling of activated primary human CD4+ T cells treated with metformin and 2-deoxyglucose

| PRJNA605014 | ENA

Metformin and 2-Deoxyglucose Collaboratively Suppress Human CD4+ T Cell Inflammatory Functions and Activation-Induced Metabolic Reprogramming

Project description:This SuperSeries is composed of the SubSeries listed below.

2020-06-15 | GSE144354 | GEO

Effect of metformin on 24 hour culture of SLE CD4 T cells and Healthy Control CD4 T cells

Project description:Investigate the effect of 1.0 mM Metformin on CD4 T cells from Systemic Lupus Patients and compare to Healthy Control CD4 T cells

2019-04-01 | GSE119446 | GEO

Targeted RNASeq using a custom panel of metabolic genes

Project description:Purpose: The purpose of this experiment was to determine the time point following activation at which greatest transcriptional differences in metabolic genes were observed between primary human CD4+ T cells treated with metformin + 2-deoxyglucose combination regimen and cells treated with vehicle. Methods: Targeted RNA-Seq data was generated from primary human CD4+ T cell mRNA using a Qiagen custom designed panel of metabolic genes and the Illumina TruSeq stranded mRNA prep. Results: We obtained differential gene expression between metformin + 2-deoxyglucose and vehicle-treated cells using the DESeq2 app in Illumina Basespace for a set of metabolic genes during different time points following activation, and found the greatest changes at 24hr.

2020-06-15 | GSE144352 | GEO

2-Deoxyglucose induced transcription in control and MondoA knockdown cells

Project description:To determine the contibution of the transcription factor MondoA to 2-deoxyglucose-induced transcription expression analysis was carried out in control and MondoA knockdown cells HA1ER cells are human embryonic kidney cells transformed with hTERT, SV40 Early region and activated H-Ras Keywords: cell type comparision, genetic modification HA1ER cells, Control (NS) or MondoA knockdown (M2), were starved for glucose overnight and then treated with 2-deoxyglucose for 3 hours

2008-04-24 | E-GEOD-11242 | biostudies-arrayexpress

Senescent cells suppress innate VSMC repair functions in atherosclerosis

Project description:Senescent cells suppress innate VSMC repair functions in atherosclerosis

| PRJNA702591 | ENA

Metformin regulated genes in human prostate cancer cells

Project description:The biguanide metformin has been shown to not only reduce circulating glucose levels but also suppress in vitro and in vivo growth of prostate cancer. However, the mechanisms underlying the anti-tumor effects of metformin in advanced prostate cancers are not fully understood. The goal of the present study was to define the signaling pathways regulated by metformin in androgen-receptor (AR) positive, castration-resistant prostate cancers. Our group used RNA sequencing (RNA-seq) to examine genes regulated by metformin within the C4-2 human prostate cancer cell line. Western blot analysis and quantitative RT-PCR were used to confirm alterations in gene expression and further explore regulation of protein expression by metformin. Data from the RNA-seq analysis revealed that metformin alters the expression of genes products involved in metabolic pathways, the spliceosome, RNA transport, and protein processing within the endoplasmic reticulum. Gene products involved in ErbB, insulin, mTOR, TGF-, MAPK, and Wnt signaling pathways are also regulated by metformin. A subset of metformin-regulated gene products were genes known to be direct transcriptional targets of p53 or AR. Together, our results suggest metformin regulates multiple pathways linked to tumor growth and progression within advanced prostate cancer cells.

2022-02-10 | GSE196343 | GEO

Brugia malayi filarial helminth-derived extracellular vesicles suppress antigen presenting cell functions and antigen-specific CD4+ T cell responses

Project description:Brugia malayi filarial helminth-derived extracellular vesicles suppress antigen presenting cell functions and antigen-specific CD4+ T cell responses

| PRJNA1098733 | ENA

Senescent cells suppress innate vascular smooth muscle cell repair functions

Project description:Senescent cells suppress innate vascular smooth muscle cell repair functions

| PRJNA539958 | ENA